Related scientific articles (all)

In Regard to Perrier et al.

Authors : Escande A, Van Gestel D, Lacornerie T, Marchesi V, Florescu C, Guemnie-Tafo A, Peiffert D, Lisbona A, Deutsch E, Mirabel X
Year : 2017
Journal : Int J Radiat Oncol Biol Phys
Volume : 97
Pages : 204-205

Breast cancer treatment-induced cardiotoxicity.

Authors : Martel S, Maurer C, Lambertini M, Pondé N, de Azambuja E
Year : 2017
Journal : Expert Opin Drug Saf
Volume : 16(9)
Pages : 1021-1038

Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical Review.

Authors : Najar M, Krayem M, Meuleman N, Bron D, Lagneaux L
Year : 2017
Journal : Immune Netw
Volume : 17
Pages : 89-102

Targeting immune checkpoints in breast cancer: an update of early results.

Authors : Solinas C, Gombos A, Latifyan S, Piccart-Gebhart M, Kok M, Buisseret L
Year : 2017
Journal : ESMO Open
Volume : 2
Pages : e000255

Nouvelles promesses de l'immunothérapie pour les carcinomes épidermoïdes de la tête et du cou : entre rationnel scientifique et efficacité clinique

Authors : Lalami Y
Year : 2017
Journal : Nucl Recept Signal
Volume : 10(7)
Pages : 59-65

Value of the 68Ga-DOTATATE PET-CT in the diagnosis of endometriosis. A pilot study.

Authors : Fastrez M, Artigas C, Sirtaine N, Wimana Z, Caillet M, Rozenberg S, Flamen P
Year : 2017
Journal : Eur J Obstet Gynecol Reprod Biol
Volume : 212
Pages : 69-74

Absence of clinical cerebellar syndrome after serial injections of more than 20 doses of gadoterate, a macrocyclic GBCA: a monocenter retrospective study.

Authors : Perrotta G, Metens T, Absil J, Lemort M, Manto M
Year : 2017
Journal : J Neurol
Volume : 264
Pages : 2277-2283

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

Authors : Von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber Rd, Piccart-Gebhart M, Baselga J
Year : 2017
Journal : N Engl J Med
Volume : 377(2)
Pages : 122-131

Place des antibiotiques dans le traitement de la rhinosinusite chronique ? Analyse

Authors : Sculier JP
Year : 2017
Journal : Minerva
Volume : 16(3)
Pages : 61-64

The Intensive Care Medicine research agenda on critically ill oncology and hematology patients.

Authors : Azoulay E, Schellongowski P, Darmon M, Bauer PR, Benoit D, Depuydt P, Divatia JV, Lemiale V, van Vliet M, Meert AP, Mokart D, Pastores SM, Perner A, Pène F, Pickkers P, Puxty KA, Vincent F, Salluh J, Soubani AO, Antonelli M, Staudinger T, von Bergwelt-Baildon M, Soares M
Year : 2017
Journal : Intensive Care Med
Volume : 43(9)
Pages : 1366-1382

Peritumoral indocyanine green fluorescence injection during transanal total mesorectal excision to identify the plane of dissection.

Authors : Dapri G, Cahill R, Bourgeois P, Liberale G, Gomez Galdon M, Cadière GB
Year : 2017
Journal : Colorectal Dis
Volume : 19(6)
Pages : 599-600

Allogeneic haematopoietic cell transplantation for indolent lymphomas: Guidelines from the Francophone Society Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Authors : Gauthier J, Chantepie S, Bouabdallah K, Jost E, Nguyen S, Gac AC, Damaj G, Duléry R, Michallet M, Delage J, Lewalle P, Morschhauser F, Salles G, Yakoub-Agha I, Cornillon J
Year : 2017
Journal : Bull Cancer
Volume : 104(12s)
Pages : s121-s130

L'éditorial du redacteur en chef.

Authors : Berghmans T
Year : 2017
Journal : Rev Med Brux
Volume : 38
Pages : 201

Immunology of Solid Tumors Beyond Tumor-Infiltrating Lymphocytes: The Role of Tertiary Lymphoid Structures

Authors : Van den Eyden G, Salgado R, Willard-Gallo K
Year : 2017
Journal : Springer nature
Volume : -
Pages : 259-280

A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT0006

Authors : Tryfonidis K, Basaran G, Bogaerts J, Debled M, Dirix L, Thery JC, Tjan-Heijnen VC, Van den Weyngaert D, Cufer T, Piccart-Gebhart M, Cameron D
Year : 2016
Journal : Eur J Cancer
Volume : 53
Pages : 144-54

Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea: proof of concept.

Authors : VAN DEN Heuvel B, Peeters M, Hendlisz A, Van den Eynde M, Machiels G, Dero I, Geboes K, De Man M, Hendrickx K, Delaunoit T, Monsaert E, Vanderstraten E, Van Laethem JL, Lybaert W, Holbrechts S, Rolfo C
Year : 2016
Journal : Minerva Chir

Drugs prescribed for patients hospitalized in a geriatric oncology unit: Potentially inappropriate medications and impact of a clinical pharmacist.

Authors : Deliens C, Deliens G, Filleul O, Pepersack T, Awada A, Piccart-Gebhart M, Praet JP, Dal Lago L
Year : 2016
Journal : J Geriatr Oncol
Volume : 7(6)
Pages : 463-70

Adding checkpoint inhibitors to tyrosine kinase inhibitors targeting EGFR/ALK in non-small cell lung cancer: a new therapeutic strategy.

Authors : Tabchi S, Kourie HR, Kattan J
Year : 2016
Journal : Invest New Drugs
Volume : 34(6)
Pages : 794-6

Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial.

Authors : Loi S, Dafni U, Karlis D, Polydoropoulou V, Young BM, Willis S, Long B, de Azambuja E, Sotiriou C, Viale G, Rüschoff J, Piccart-Gebhart M, Dowsett M, Michiels S, Leyland-Jones B
Year : 2016
Journal : JAMA Oncol
Volume : 2(8)
Pages : 1040-7

Which factors predict overall survival in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate post-docetaxel?

Authors : Van Praet C, Rottey S, Van Hende F, Pelgrims G, Demey W, Van Aelst F, Wynendaele W, Gil T, Schatteman P, Filleul B, Schallier D, Machiels JP, Schrijvers D, Everaert E, DHondt L, Werbrouck P, Vermeij J, Mebis J, Clausse M, Van Erps J, Verheezen J, Van Haverbeke J, Goeminne JC, Lumen N
Year : 2016
Journal : European urology supplements
Volume : 15(3)
Pages : -